Effects of molsidomine and other NO-containing vasodilators on cyclic GMP formation.
D000818:Animals; D001711:Biotransformation; D002118:Calcium / Q000502:physiology; D006152:Cyclic GMP / Q000096:biosynthesis*; D006801:Humans; D008981:Molsidomine; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D010069:Oxadiazoles / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D013558:Sydnones / Q000378:metabolism / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D010069:Oxadiazoles; D013558:Sydnones; D014665:Vasodilator Agents; D008981:Molsidomine; D006152:Cyclic GMP; D002118:Calcium